1. Immunomodulatory effects of mesenchymal stem cells
2. Cell therapy and stem cell therapy in autoimmune disease
3. Mesenchymal stem cells
4. Exosomes derived from stem cells and immune cells
5. Tolerogenic dendritic cells

[1] N. Abbasi, S. M. Hashemi, M. Salehi, H. Jahani, S. J. Mowla, M. Soleimani, and H. Hosseinkhani, “Influence of oriented nanofibrous PCL scaffolds on quantitative gene expression during neural differentiation of mouse embryonic stem cells.,” J. Biomed. Mater. Res. A, vol. 104, no. 1, pp. 155–64, Jan. 2016.
[2] A. Ardeshirilajimi, F. Rafeie, A. Zandi-Karimi, G. A. Jaffarabadi, A. Mohammadi-Sangcheshmeh, R. Samiei, A. Toghdory, E. Seyedjafari, S. M. Hashemi, M. U. Cinar, and E. L. Gastal, “Fat harvesting site is an important determinant of proliferation and pluripotency of adipose-derived stem cells,” Biologicals, vol. 44, no. 1, pp. 12–18, Dec. 2016.
[3] Z. Hosseinpur, S. M. Hashemi, E. Salehi, and T. Ghazanfari, “Comparison of TGF-β1 and NO production by mesenchymal stem cells isolated from murine lung and adipose tissues,” Immunopharmacol. Immunotoxicol., vol. 3973, no. April, pp. 1–7, Apr. 2016.
[4] H. R. Jamal Mohammadi Ayenehdeh, Bahareh Niknam, Seyed Mahmoud Hashemi and N. T. Nima Rezaei, Masoud Soleimani, “Introducing a new experimental islet transplantation model using biomimetic hydrogel and a simple high yield islet isolation technique,” Iran. Biomed. J., 2016.
[5] F. Yousefi, M. Ebtekar, S. Soudi, M. Soleimani, and S. M. D. Hashemi, “In Vivo Immunomodulatory Effects of Adipose-Derived Mesenchymal Stem Cells Conditioned Medium in Experimental Autoimmune Encephalomyelitis.,” Immunol. Lett., vol. 172, pp. 94–105, Feb. 2016.
[6] S. Dameshghi, A. Zavaran-Hosseini, S. Soudi, F. J. Shirazi, S. Nojehdehi, and S. M. Hashemi, “Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice,” Immunol. Lett., vol. 170, pp. 15–26, Feb. 2015.
[7] N. M. Kalanaky S, Hafizi M, Fakharzadeh S, Vasei M, Langroudi L, Janzamin E, Hashemi SM, Khayamzadeh M, Soleimani M, Akbari ME, “BCc1 , the novel antineoplastic nanocomplex , showed potent anticancer effects in vitro and in vivo,” Drug Des. Devel. Ther., vol. 10, pp. 59–70, 2015.
[8] L. Langroudi, Z. M. Hassan, and M. Soleimani, “Tumor Associated Mesenchymal Stromal Cells Show Higher Immunosuppressive and Angiogenic Properties Compared to Adipose Derived MSCs,” Iran J. Immunolgy, vol. 12, no. 4, pp. 226–239, 2015.
[9] H. Mohammadpour, A. A. Pourfathollah, M. Nikougoftar Zarif, and S. M. Hashemi, “Increasing proliferation of murine adipose tissue-derived mesenchymal stem cells by TNF-α plus IFN-γ,” Immunopharmacol.
[10] M. Mondanizadeh, E. Arefian, G. Mosayebi, M. Saidijam, B. Khansarinejad, and S. M. Hashemi, “MicroRNA-124 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Targeting Sp1 mRNA,” J. Cell. Biochem., vol. 116, no. 6, pp. 943–953, 2015.
[11] S. Oraee-Yazdani, M. Hafizi, a Atashi, F. Ashrafi, a-S. Seddighi, S. M. Hashemi, a Seddighi, M. Soleimani, and a Zali, “Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome,” Spinal Cord, no. November 2014, pp. 1–8, 2015.
[12] H. Rahavi, S. M. Hashemi, M. Soleimani, J. Mohammadi, and N. Tajik, “Assessing in vitro inhibitory effect of adipose-derived mesenchymal stem cells on C57BL/6 diabetic mouse splenocytes proliferation,” Razi J. Med. Sci., vol. 22, no. 132, pp. 95–106, 2015.
[13] H. Rahavi, S. M. Hashemi, M. Soleimani, J. Mohammadi, and N. Tajik, “Adipose Tissue-Derived Mesenchymal Stem Cells Exert In Vitro Immunomodulatory and Beta Cell Protective Functions in Streptozotocin-Induced Diabetic Mice Model,” J. Diabetes Res., vol. 2015, pp. 1–10, 2015.
[14] A. Mohammadzadeh, A. A. Pourfathollah, S. Shahrokhi, S. M. Hashemi, S. L. A. Moradi, and M. Soleimani, “Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors of T cell subsets,” Int. Immunopharmacol., vol. 20, no. 2, pp. 316–321, 2014.
[15] M. Naderi, H. Abdul Tehrani, M. Soleimani, I. Shabani, and S. M. Hashemi, “A Home-brew Real-time PCR Assay for Reliable Detection and Quantification of Mature miR-122.,” Appl. Immunohistochem. Mol. Morphol., vol. 00, no. 00, pp. 1–6, Dec. 2014.
[16] I. Shabani, V. Haddadi-Asl, M. Soleimani, E. Seyedjafari, and S. M. Hashemi, “Ion-exchange polymer nanofibers for enhanced osteogenic differentiation of stem cells and ectopic bone formation.,” ACS Appl. Mater. Interfaces, vol. 6, no. 1, pp. 72–82, Jan. 2014.
[17] M. T. Tahoori, A. A. Pourfathollah, M. Soleimani, E. Vasheghani-Farahani, A. Mohammadzadeh, A. Amari, S. M. Hashemi, and M. Mossahebi-Mohammadi, “Fibroblasts feeder niche and Flt3 Ligand as a novel inducer of plasmacytoid dendritic cells development in vitro.,” Int. Immunopharmacol., vol. 24, no. 2, pp. 474–480, Nov. 2014.
[18] T. G. Ensie Sadat Mirsharif, Sakine Moaied Mohseni , Eisa Salehi, Seyed Mahmoud Hashemi, Mirsharif, M. Moaied, Salehi, Hashemi SM, and Ghazanfari, “Comparison of nitric oxide secretion by human adipose tissue-derived mesenchymal stem cells in healthy pregnant women and those with preeclampsia,” Daneshvar Med., vol. 20, no. 105, pp. 1–11, 2013.
[19] S. M. Hashemi, Z. M. Hassan, A. A. Pourfathollah, S. Soudi, A. Shafiee, and M. Soleimani, “Comparative immunomodulatory properties of adipose-derived mesenchymal stem cells conditioned media from BALB/c, C57BL/6, and DBA mouse strains.,” J. Cell. Biochem., vol. 114, no. 4, pp. 955–65, Apr. 2013.
[20] S. M. Hashemi, Z. M. Hassan, A. A. Pourfathollah, S. Soudi, A. Shafiee, and M. Soleimani, “In vitro immunomodulatory properties of osteogenic and adipogenic differentiated mesenchymal stem cells isolated from three inbred mouse strains.,” Biotechnol. Lett., vol. 35, no. 1, pp. 135–42, Jan. 2013.
[21] G. T. Hosseinpur Z, Hashemi SM, Salehi E, “Mesenchymal Stem Cell Isolation from Adipose and Lung Tissues of BALB/c Murine and Comparison of Their Immunophenotype,” ZUMS Journal., 2013.
[22] 3 and Seyed Mahmoud Hashemi Sara Soudi, M.Sc., 1 Ahmad Zavaran-Hosseini, Ph.D., 1,* Zuhair Muhammad Hassan, Ph.D., 1 Masoud Soleimani, Ph.D., 2 Fatemeh Jamshidi Adegani, M.Sc., “Comparative Study of The Effect of LPS on The Function of BALB/c and C57BL/6 Peritoneal Macrophages,” cell J., vol. 15, no. 1, pp. 45–54, 2013.
[23] S. O. Yazdani, M. Hafizi, a R. Zali, a Atashi, F. Ashrafi, a S. Seddighi, and M. Soleimani, “Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury,” Cytotherapy, vol. 15, no. 7, pp. 782–791, 2013.
[24] F. Yousefi, M. Ebtekar, M. Soleimani, S. Soudi, and S. M. Hashemi, “Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE),” Int. Immunopharmacol., vol. 17, no. 3, pp. 608–616, 2013.
[25] E. Babaei, M. Sadeghizadeh, Z. M. Hassan, M. A. H. Feizi, F. Najafi, and S. M. Hashemi, “Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo.,” Int. Immunopharmacol., vol. 12, no. 1, pp. 226–34, Jan. 2012.
[26] A. Mohammadi-Sangcheshmeh, M. Soleimani, H. Deldar, M. Salehi, S. Soudi, S. M. Hashemi, K. Schellander, and M. Hoelker, “Prediction of oocyte developmental competence in ovine using glucose-6-phosphate dehydrogenase (G6PDH) activity determined at retrieval time.,” J. Assist. Reprod. Genet., vol. 29, no. 2, pp. 153–8, Feb. 2012.